Oncology & Cancer

A novel molecule could spur new class of drugs for breast cancer

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients ...

Oncology & Cancer

Breast cancer drug in first human clinical trial

A University of Illinois at Chicago-developed breast cancer drug that has the potential to help women whose cancer has stopped responding to hormone therapy recently entered its first human clinical trial.

Oncology & Cancer

New gene discovered driving drug resistance

Scientists in Salford, U.K., have identified a gene which is 'revving the engine of cancer' against the world's most common breast cancer drug.

page 2 from 6